chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Transported to Emergency  by ambulance.  Ran blood work, MRI, CAT, hard ECHO, administered antibotics and ran extensive testing to identify potential sources that could cause illness after vaccination.
February 27th -- 2 weeks after vaccine number 2, I awoke at 2 am shaking with chills, a fever of 103, shortness of breath, high heart rate, low oxygen saturation rate, coughing and a feeling of heaviness on my chest.  Later in the day, my primary care physician's on-call doctor told me to call 911 and go to the ER, assuming this  must be COVID.  Hospital ER diagnosed pneumonia but I didn't believe it.  March 17th, I visited my primary care physician after drawing blood in the lab, doing another chest X-ray and an echocardiogram.  March 18th, the echocardiogram report filed showed reduction in ejection fraction to about 30-35 percent (from what had been a normal 55 to 60% before the vaccines).  Cardiology started a beta blocker drug and I was referred on to pulmonology and gastroenterology for additional testing.  May 9th, the exact same symptoms occurred at around 2 am, which necessitated another visit to the ER, again with the same pneumonia diagnosis.  Still don't believe I had pneumonia but did go through two rounds of two different antibiotics each.  Just had my 2nd echo a few weeks ago and the ejection fraction is up to 40, but cardiologist doesn't "like the way the heart" looks.  All of these medical visits and explorations are in an effort to truly understand what has happened to my body -- I am slow and sluggish, can't walk more than 4 blocks without being winded, and of course am staying alone in my high-rise apartment most of the time.  I still believe this is vaccine related myocarditis.
Has not received the second dose, 2 months after the first dose; Tingling on the tongue; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Tingling on the tongue) and PRODUCT DOSE OMISSION ISSUE (Has not received the second dose, 2 months after the first dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     Concurrent medical conditions included Bee sting hypersensitivity.    On 18-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced PARAESTHESIA ORAL (Tingling on the tongue). On 21-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received the second dose, 2 months after the first dose). On 21-Jul-2021, PRODUCT DOSE OMISSION ISSUE (Has not received the second dose, 2 months after the first dose) had resolved. At the time of the report, PARAESTHESIA ORAL (Tingling on the tongue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.  Patient always carries an EpiPen with her as she's allergic to Bee stings.
Pt had chills times 1 day, N&V times 4 days and L extremity pain dorsum post vaccination. Sought medical care 3 days post vax with treatment with LMD with otc analgesic and anti-emesis. All conditions resolved with no further problems noted.
PATIENT GOT UP TO LEAVE AND PASSED OUT. CAREGIVER CAUGHT HER. SHE WAS PALE AND SAID SHE FELT WHOOZY. SHE WAS GIVEN WATER AND A POPSICLE AND PROPPED HER FEET UP. SHE REMAINED IN THE PHARMACY FOR 15 ADDITIONAL MINUTES.
COVID 19 INFECTION; .This spontaneous report received from a patient concerned a 40 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, and seasonal allergies, and other pre-existing medical conditions included patient had no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, and batch number: 1802072 expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced covid 19 infection. On 08-APR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid 19 infection was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious
Initial consumer report received on 13 Aug 2010: This patient received H1N1 (manufacturer unknown) unknown dose intramuscularly in fall 2009. As the manufacturer was unknown it was conservatively taken as Influenza virus vaccine pandemic INN. On an unknown date, 24 hours after receiving the vaccine, the patient experienced chills and generalized muscle weakness which lasted roughly 12 hours. The outcome of the event was reported as complete recovery. Follow-up report received from a consumer on 30 Aug 2010:The reporter stated that she was not shot (vaccinated) at pharmacy and did not see her nurse after the reaction. After 18 hrs of vaccination, the patient was doing better and by second day she was back to normal. The patient's husband reported about the reaction.
I was sick with covid in January of 2021.  I did not lose ability to smell but did lose sense of taste for about 1 week.  Taste was restored fully over time.  I received the first covid vaccination May 14th, 2021.  My reaction was rather severe but after a couple of days rest I was fine with no lingering effects.  I received the second dose of vaccine on 02 June 2021 and had a much more severe reaction, took a bit over three days to recover.  My sense of smell and taste have been off ever since.  I get a strong chemical smell from most things and many foods have a new bad flavor.  Both milk and peanuts (and peanut products) used to be staples in my diet - now I dislike their taste (for an example).   I received my vaccinations from the local healthcare facility.
Severe Headache for 20 hours, Nausea, Vomiting, Chills, Felt feverish.
3 days p/vax devel fever, sore throat, swollen glands, nausea;seen @ clinic 9 days post vax;also had hives the prev day;
This spontaneous report was received from a licensed practical nurse concerning an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On an unknown date, the unspecified number of patients were vaccinated with unspecified number of doses of improperly stored (Oka/Merck) VARIVAX, lot # L039092, expiration date 06-OCT-2017. No adverse effects reported. The reporter stated that the doses were exposed to -13.3C during 11 days. On 16-MAR-2016, a phone call was received from the reporting licensed practical nurse, who stated that was unable to share any patient identifiers or dates of vaccination the time of this report. This is one of several reported received from the same reporter. Additional information has been requested.
Information has been received from a licensed practical nurse concerning a 7 month old white male (birth weight 7lbs. 2.5oz, no. of siblings was 1) who on 11-DEC-2006 was vaccinated with the first dose of PEDVAXHIB (OMPC), (lot #653525/0279F), IM right.  Concomitant therapy included the first dose of PEDIARIX, (lot #AC21B5H79), IM right and the first dose of PREVNAR, (lot #B08672K), IM left.  Other concomitant medications were not reported.  On 19-FEB-2007, the patient was vaccinated with the second dose of the following medications PEDIARIX, (lot #AC21B071AA), PREVNAR, (lot #B08672K), and ROTATEQ (MSD) (lot #656103/1166F), oral.  On 13-MAR-2007 at 12:35 pm, the patient experienced diarrhea.  The patient was placed on Isomil OF.  On 29-MAR-2007, a stool sample was taken which tested positive for ROTATEQ.  As of 16-APR-2007, the patient still experienced diarrhea.  The patient recovered from the events on an unspecified date.  Additional information is not expected.
Tinnitus ringing in ears; Sleeping difficult; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 2, single (Lot number: EW0168), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis" (unspecified if ongoing); "Egg allergy" (unspecified if ongoing). Concomitant medication(s) included: GILENYA. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; lot number : EW0153 ; anatomical location: Left arm), administration date: 09Apr2021, when the patient was 43-year-old, for COVID-19 immunization. The following information was reported: TINNITUS (non-serious), 5 days after the suspect product(s) administration, outcome "recovered", described as "Tinnitus ringing in ears"; INSOMNIA (non-serious), 5 days after the suspect product(s) administration, outcome "recovered", described as "Sleeping difficult".   No follow-up attempts are possible. No further information is expected.
Low Grade Fever (99.7); chills/shivers, upset stomach; some stomach pain; very tired/fatigue; muscle aches (especially in neck going up into my head and upper back/shoulders; pain/soreness at injection site; redness at injection site
Patient reported a rash at the site of injection, the rash started 2 days after moderna covid vaccine. Rash was pink, itchy, raised, and the size of a half dollar. Patient did not take anything to treat symptoms.
Received second dose of Pfizer vaccine on 3/22; patient developed herpes zoster ophthalmicus OS on 3/30; of note patient has history of HSV-1 encephalitis and will be undergoing immunodeficiency work up.
Hours after receiving the first set of recommended vaccines for our daughter, she got a high fever and was extremely lethargic. She wasn't sleepy, it was like she was losing consciousness.  She was hard to wake up and had a glassy and glazed stare. She couldn't even focus on you while we spoke to her or tried to get her attention. This was completely out of character for her and first time we had ever witnessed such behavior/fever (around 101.0, 102.0 and climbing)
I felt very fatigued, dizzy, headache, and some nausea about 1 hour after vaccine. Next day I developed an infection in my upper R molar. It has had no problems and has had a cap on it for years. The infection started to radiate into my right eye and become extremely painful on next day. I went to see a dentist as soon as I could get in - he said there was a very large infection around that tooth and put me on antibiotics - clindamycin 150 mg for 7 days.  I have been woozy and nauseous off and on since I started taking it. My right eye has experienced blurry vision off and on as well as a weird pressure.   I don't know if the vaccine had anything to do with the development of this infection or the spread of it - is that possible? Will this development, antibiotic use, and subsequent dental work be affected or affect my second dose coming up in a week?
Severe headache for 12 hrs, dramatic muscle twitching, arms & legs for 12 hrs. Could not sleep & could not stop moving for the 12 hrs. Raised, sore, red & hot welt (silver dollar size) on arm for 5 days now.
headache, sore throat, nonproductive cough, "low grade" fever, body aches, loss of taste, runny nose, congestion. starting on 11/2/21
Information was received from an attorney regarding a case in litigation concerning a female patient of unknown age. Medical history, concurrent conditions and concomitant medications were not provided. In or about 15-FEB-2017, the patient was inoculated at a pharmacy with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 12-MAY-2017, the patient was treated at physician office for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long term prevention of shingles. The patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
A report was received from a health care professional on 2/24/04 concerning up to 8 vaccinees under 4 years of age and of unknown gender who inadvertently received a dose of Fluvirin vaccine on an unreported day in December 2003. On an unspecified day in December 2003, up to 8 vaccinees were inadvertently administered Fluvirin. The outcome of the event was not reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 3/22/04: Further information was received from a health care professional indicating that the vaccinee was a 40 month old female who inadvertently received 0.5ml Fluvirin on 1/15/04. No adverse events were reported at the time of the event. No follow up pending. All information received.
Breakthrough case admission after 3 vaccines Moderna 3/6/21 Lot# 029A21A;  Moderna 4/3/21 Lot3 028a21a;  Moderna 10/29/21 Lot# 077C21B
fatigue/Tiredness; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (fatigue/Tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 01-Feb-2021, the patient experienced FATIGUE (fatigue/Tiredness). At the time of the report, FATIGUE (fatigue/Tiredness) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   Reporter did not allow further contact
Systemic rash all over body for +3 days, Bloody nose for 2 weeks, Congestion for two weeks.
Numbness to the left arm after injection; diaphoretic, dizzy, weak shortly after.  No significant past medical history  Vital Signs: @3:45pm HR 68, R 18, BP 132/87 O2 98%  @ 3:50pm HR 70, R 18, BP 115/70,  O2 97%
male at day 12 PV unilateral dermatoma L flank and altered skin sensation.; This is a spontaneous report from contactable physician. This contactable physician reported that, a 48-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as a DOSE 1, SINGLE for covid-19 immunisation. The patient medical history included varicella from an unknown date and unknown if ongoing reported as, HX of chickenpox at age 8, that was treated with valacyclovir and Gapapentin. Was PCR postive. The patient's concomitant medications were not reported. It was reported that the male at day 12 PV unilateral dermatoma, l flank and altered skin sensation, on an unspecified date. Event took place after use of product. The patient underwent lab tests and procedures which included polymerase chain reaction that was pcr on an unspecified date. Outcome of the event was unknown.  Information about batch/lot number has been requested.
aside from the normal body chills I felt my throat get slightly swollen, reaction was stronger during the first several minutes & was less but still felt for the following hour and a half
The patient presented on 10/19/21 with purple bruising starting about 4 finger widths from the Acromion Process and extending to just above the elbow. It also extended around the arm but did not completely encricle it. Above and below the purple bruising a faint yellow tint extened a few inches. There was not evidence of red streaks and the patient stated that he had not seen any. The area was warm but not any different than the unbruised areas of the arm. He had not called his doctor and I told him he should contact them as soon as he got home. I told the patient I would also contact the doctor. The office scheduled him an appointment for 10/21/21.
pt recvd vax; redness & swelling started 18feb95 & has progressively worsened;
Sciatic pain has returned and has continued to hurt everyday since that time; Intermittent pain that begins in her knee and travels down her leg; Intermittent pain that begins in her knee and travels down her leg; This is a spontaneous report from a contactable consumer (patient).   A 67-year-old female consumer reported for herself who received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 23Feb2021 (at the age of 67-year-old) as dose 2, single for covid-19 immunization. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. Medical history included sciatic pain has returned and ongoing. The patient's concomitant medications were not provided. After receiving the second dose of vaccination, patient reported that her sciatic pain has returned and continued to hurt everyday as intermittent pain that begins in her knee and travels down her leg on an unspecified date. The outcome of the event sciatic pain has returned and continued to hurt everyday was reported as not recovered and other events reported as unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be requested.
no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 07-FEB-2023, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This one of several case received from the same reporter. ; Sender's Comments:  US-009507513-2304USA002221:
Expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered). On 07-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Expired doses administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  On 06-Dec-2021, the vial with Lot 012H21B was in the refrigerator, upon receiving.  No treatment information was provided.
shot on 08FEB2021 and is about to go beyond the 42 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (shot on 08FEB2021 and is about to go beyond the 42 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (shot on 08FEB2021 and is about to go beyond the 42 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (shot on 08FEB2021 and is about to go beyond the 42 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications provided. No treatment information provided.
This spontaneous report as received from a physician via company representative refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 for prophylaxis (strength, dose, frequency, route, lot # and expiry date were not reported). On an unknown date, shortly after receiving the PNEUMOVAX 23, the patient passed away (death). The cause of death was not reported. It was unknown if autopsy was performed. Causality assessment was not reported. Reported Cause(s) of Death: unknown cause of death.
Patient inadvertently received vaccine after published expiration date. Moderna Company analyzed lot 007B21A and advised vaccine maintained  activity needed to protect against covid 19 on date vaccine was administered. Also patient did not call in to complain of adverse event.  This is administrative error without adverse event.
Narrative: Patient developed a rash following administration of pfizer covid vaccine. Patient was prescribed tramcinolone ointment to manage the rash.
Vomiting. BPs 87/54 (pulse 95), 98/63 (pulse 71).